United States: CMS Proposes Payment Reform/Cap Adjustments

On April 30, 2015, CMS released its FY 2015 Hospice Wage Index, including long anticipated payment reform and some changes to the hospice cap calculation.  Comments are due by June 29.  Here is an initial summary and analysis.

Routine Home Care Payment Reform

For years, MedPAC has urged CMS to revamp hospice reimbursement to match what it claims is more actual expense at the beginning and end of hospice service (first and last 7 days), the so-called U-shaped curve.  MedPAC's analysis, focusing just on skilled nursing visits, has long ignored key aspects of the hospice benefit including pharmacy, other types of visits, and DME.

We have previously noted that there is arguably no need or policy justification to pay significantly more for just the first 7 days of care since: (a) very short hospice stays are not best for beneficiaries or Medicare; and (b) hospices already have ample incentive to serve very short stay patients in terms of earning significant cap allowances (even if such stays cost hospices more).

CMS now proposes to shift payment for routine home care but does not exactly follow the MedPAC suggestion.  Instead, CMS proposes to pay just under 20% more for the first 60 days and just under 10% less for every day of care thereafter.  This proposed change would, if adopted, begin October 1, 2015.

So for instance, prior to regional wage level adjustment, CMS notes that routine home care would be $159 in FY 2016; after adjustment it would be $187 for the first 60 days and $145 for days 61+.

CMS anticipates the problem of a patient with a significant gap in hospice care (live discharge / later readmission) by providing that the higher first 60 day rate structure will renew if there is at least a 60 day gap in care.  This reset should encourage re-admission of patients but could also prove problematic.

The breakeven point for hospices for any one patient, assuming no gap reset, falls near 170 days of care.  For a provider overall, it appears that provider must have between 35-40% of its patients under 61 days on service at any given point in time, or its overall revenue will decline (before the SIA adjustment below).  Many hospices will not meet this test and will therefore experience a decline in revenue of between 3-5% almost immediately.

Given that the median length of stay (LOS) is approximately 15 days and average LOS is closer to 80 days, the fact is that almost all hospices have some long stay patients.  This is a natural function of the uncertain dying process and not any type of conspiracy.

One potential benefit of this adjustment will be that the hospice industry may finally have to stop targeting cap hospices and instead acknowledge the basic structural challenge of running a program with uncertain life expectancy.  CMS criticizes live discharges, perhaps rightly, but then blames hospices for long stays, failing to acknowledge the complexity of life expectancy and terminal illness.

The proposed adjustment is still arguably more reasonable than that proposed by MedPAC.  Although nominally tied to an Abt Associates cost analysis, the proposed adjustment may also reflect an appreciation by CMS that length of stay in hospice is not ideal at 7 days but should be longer.  60 days is enough time for the patient and family to realize some of the unique benefits of hospice care while also perhaps conserving at least some expensive traditional end of life care.   The 60 day change corresponds to a well-respected Duke study that urged CMS to promote longer, not shorter lengths of hospice stay.

Although 60 day hospice service periods may be "ideal," they are in fact relatively rare.  The substantial majority of hospice patients either pass away quickly or live a long time on service while declining slowly or sporadically (as reflected by the median and average LOS above).  Both types of patients are eligible.  CMS should keep in mind that although its total spend on hospice has grown nominally to $15 billion, this spend is still less than 10% of the money that Medicare spends on beneficiaries in the last six months of life.  Let's say that again: less than 10%.

Hospices do not "recruit" patients; instead, they receive them by way of referral from other corners of the Medicare system (willing doctors, hospitals, nursing facilities).  Given the lack of control in the referral relationship, the low relative cost of the benefit, and its favored status among beneficiaries and their families, CMS should err on the side of protecting this vulnerable and under-lobbied benefit.

CMS also proposes to allow hospices to bill in the last 7 days of care (for a patient that passes away) for up to 4 hours per day of RN or social worker time spent with patients otherwise receiving only routine home care.  CMS calls this a Service Intensity Adjustment (SIA).  CMS limits the SIA by precluding the SIA to SNF/NF based patients (in part addressing OIG's old claim that nursing home care is somehow duplicative of hospice) and limiting it (somewhat arbitrarily) to RNs and Social Workers.  Some of the best hospice work is done by LPNs, home health aides, and chaplains, who are left out by this adjustment.

As a result, the SIA is very limited and really only pays lip service to the idea of a boost in payment for the last few days of care.  This outcome may be preferable to highly technical and significant new payment streams that could in fact be paid out in a quite disparate fashion and could otherwise require bigger cuts to routine home care rates.

Hospice Cap Changes

CMS proposes to reset the cap accounting year to match the Federal government fiscal year, October 1 through following September 30.  This change would be made in calendar 2017 by ending the FY 2017 cap year on September 30 (a month early) and starting the FY 2018 cap year on October 1 (instead of October 31 and November 1 under the current structure, respectively).

The purpose appears to be to align the cap year to the hospice reimbursement adjustment (starts 10/1 each year).  This change might slightly reduce cap liability by trading a month of higher reimbursement (October of next rate year) for a month of lower reimbursement (October of prior rate year) beginning in FY 2018.  The alignment seems to make sense.

If adopted, the FY 2017 cap year will end September 30, 2017 instead of October 31, 2013; and, as a result, this transition cap year will only run 11 months.  The next cap year, FY 2018, will run for the new twelve month period, October 1, 2017 through September 30, 2018 (matching the reimbursement year and Federal fiscal year).

For those few providers still on the streamlined method (estimated at about 500 hospices), CMS proposes to measure streamlined allowances in the same window that it measures revenue (and pro-rated allowances), instead of shifting late-year admissions into the next cap year.  For streamlined hospices with stable patient admissions every year, this may not pose a challenge.  For others, it will result in more significant misallocations of allowances for hospices as admissions patterns change.

CMS has announced that the FY 2015 cap allowance will be $27,135.96 and that the FY 2016 allowance will be $27,624.21.  The FY 2016 allowance is the first allowance tied to hospice rate change instead of CPI-Urban and, as a result, may present a lower increase than in prior years.

CMS continues to bash hospices that exceed cap, still turning a blind eye to the real problem – the lack of good eligibility criteria, inherent uncertainty in life expectancy, and varying structure of certain hospice markets.  The cap is not something any hospice seeks out, period.  It's something that sneaks up on unwary hospices, especially ones that admit patients with prior service.   Hospices can try to avoid the cap by discharging patients that don't pass away soon enough, but they face criticism for this practice too.

Although CMS points to "many tools" available to predict life expectancy, CMS itself has the most robust information but declines to set National Coverage Determinations.  CMS should end the bashing of cap hospices and focus on open reform and education related to eligibility criteria.  Tell hospices who to serve and let them serve.

CMS also does not mention in this extensive new rule its instruction to MACs to add sequestration to the hospice cap.  This sequestration adjustment, adding money never paid to the hospice to revenue, remains contrary to statute, regulation, and policy in our view.

Related To Terminal Diagnosis

In this lengthy proposed rule, CMS also continues to cement its position that "virtually all" care a patient on hospice receives is related to the terminal diagnosis.  As previously noted, this will eventually lead to CMS attempting to charge back hospices with certain non-hospice costs.

The data that CMS offers about the nature of the problem, though, is hardly alarming.  According to CMS, Medicare spent $15 billion on hospice in FY 2013; and, CMS in turn notes that patients on hospice also received $1.3 billion in non-hospice care.  In short, with about a million patients served, at an average cost of about $15,000, CMS is complaining that an additional $1,300 in other care was provided as well.

Considering that Medicare spends about $42,500 per beneficiary in the last six months of life ($170 billion overall), the expenditure of $15,000 per beneficiary on hospice and an additional $1,300 per hospice beneficiary on unrelated care may not be the most significant issue.

It will be interesting to watch the hospice community react to payment reform in its unexpected incarnation.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Events from this Firm
29 Nov 2017, Webinar, Los Angeles, United States

This webinar will cover issues that California employers must face when managing a remote workforce of employees who “telecommute” for work. Due to the growing number of employees that work from home, California employers must know how to manage this new remote workforce in order to offer competitive career opportunities for a new generation of employees, while also being careful not to violate the complex California employment laws that govern these work arrangements.

30 Nov 2017, Conference, Brussels, Belgium

The European Competition and Regulatory Law Review (CoRe), the Computer and Communications Industry Association (CCIA) and the Vrije Universiteit Brussel (VUB) are delighted to invite you to our joint conference discussing some of today’s most frequently asked questions: Does competition law enforcement require an update for online markets?

4 Dec 2017, Conference, Virginia, United States

The Government Contract Management Symposium (GCMS) is held annually by the National Contract Management Association (NCMA) in the Washington, DC metro area. Formerly intended for those in federal sector, it has grown to provide training for professionals in both government and industry contracting.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


From time to time Mondaq may send you emails promoting Mondaq services including new services. You may opt out of receiving such emails by clicking below.

*** If you do not wish to receive any future announcements of services offered by Mondaq you may opt out by clicking here .


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.